FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September

Global Countries Impose Tariffs on Chinese Chemical Products

Rare Earth and Power: Strategic Probing Beneath the New U.S.–China Trade Framework

U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment

EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase

EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry

China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production

API Supplier Audits Move to the Center of Pharma Supply Resilience

Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure

Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room

The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share